The present stock price for Surface Oncology Inc. (SURF) is $0.87. In the last trading session, the stock made a considerable jump, reaching $0.9399 after an opening price of $0.74. The stock briefly fell to $0.7341 before ending the session at $0.74.
Surface Oncology Inc. experienced a rather shaky stock market performance. The highest value in the past year was recorded at $2.15 on 07/07/22 and the lowest value was $0.56 on 04/28/23.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
52-week price history of SURF Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Surface Oncology Inc.’s current trading price is -59.53% away from its 52-week high, while its distance from the 52-week low is 56.76%. The stock’s price range during the 52-week period has remained between $0.56 and $2.15. In the Healthcare sector, the company’s shares saw a trading volume of around 1.1 million for the day, which was evidently higher than the average daily volume of 0.19 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Surface Oncology Inc. (SURF) has experienced a quarterly rise of 20.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 49.26M and boasts a workforce of 60 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7503, with a change in price of +0.1900. Similarly, Surface Oncology Inc. recorded 227,061 in trading volume during the last 100 days, posting a change of +27.94%.
Examining SURF’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for SURF stands at 0.34. Similarly, the long-term debt-to-equity ratio is also 0.30.
SURF Stock Stochastic Average
As of today, Surface Oncology Inc.’s raw stochastic average for the last 50 days stands at 81.84%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 81.84%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 93.93% and 82.63%, respectively.
SURF Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price gain of 6.10% this year. Over the last six months, there has been a stronger performance of -17.92%. The price of SURF fallen by 36.69% during the last 30 days period. For the last 5-days stocks have improved 39.16%.
